Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
about
Hepatitis B virus: where do we stand and what is the next step for eradication?Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in EgyptPrevention of hepatitis B.Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan.Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg.Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study.Unsolved problems and future perspectives of hepatitis B virus vaccination.HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.Chronic hepatitis B infection in adolescents vaccinated at birth: an alarm bell in favor of the need for a booster?Hb and dyslipidaemia as predicting markers of serum alanine aminotransferase elevation in Chinese adolescents.Reply: To PMID 22858989.Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.Occult hepatitis B virus infection in immunized children born to carrier mothers.The Pathogenicity of and Ability to Tolerate a Wide Range of Temperatures and SalinitiesVaccines: Taking a shot at protection
P2860
Q33958764-2594CBF5-E5D1-43E3-9F54-2D08E8434119Q34235321-5884967A-35F6-4F0B-A8A1-9E6B77D69FDAQ34581747-122B6284-7B38-4AEE-92AB-AE0147ACA565Q34647572-F5F581B7-3D95-4C30-90CE-BF802B730DD5Q35164249-83F97A55-AABE-422C-8612-49931FB81413Q35539786-53C2E9E2-FCF7-42B6-98A1-DA09E728F8E8Q36988372-606B69C5-73D3-4060-9693-C32872397D25Q37605957-A55E2292-DDE0-4EFE-9A95-48B1D558FA11Q38918664-60A2F997-4552-4B98-9E37-2E0DC3D4664BQ39812218-FD48BA90-D5CD-4DCB-A87B-6B295F8DBD16Q41666724-3A648739-9904-413D-A154-AC5C1F566270Q42412334-667263D7-479C-4B58-8937-D4340B60DF18Q44066657-C430D051-6F68-4AF0-B0DF-D7E391F90A4DQ46073416-FD4D02F5-8448-400A-8AEB-E2573815C8BEQ46195606-065A69C5-B602-40DB-B755-310DF7806778Q46609358-9001A5EE-D22E-42A8-AADA-F4A394C52BA3Q48103063-78164415-45D7-41D3-BB03-C154069CB6DAQ50593538-17F95973-2C92-437C-B725-840799E95582Q53551944-57E2FFA1-CA91-4847-B8FF-276CDE1B4478Q58548846-28D94F8B-1A22-4D34-89B7-330C42862A2FQ74441535-E55BC087-D179-4F6C-ABB6-29708BC05D23
P2860
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@en
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@nl
type
label
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@en
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@nl
prefLabel
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@en
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@nl
P2093
P2860
P356
P1433
P1476
Chronic hepatitis B infection in adolescents who received primary infantile vaccination.
@en
P2093
Hans Hsienhong Lin
Li-Yu Wang
Tzu-Wei Wu
P2860
P356
10.1002/HEP.25988
P407
P577
2012-12-28T00:00:00Z